UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 3, 2023

 

ASP Isotopes Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41555

 

87-2618235

(State or other jurisdiction of

incorporation)

 

(Commission 

File Number)

 

(IRS Employer

 Identification No.)

 

1101 Pennsylvania Avenue NW, Suite 300

Washington, DC

 

 

20004

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (202) 756-2245 

 

_________________________________________________ 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Ticker

symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01

 

ASPI

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On October 3, 2023, ASP Isotopes Inc. (the “Company”) issued a letter to shareholders summarizing, among other things, the Company’s year-to-date progress in 2024 and discussing future goals. A copy of the press release is furnished as Exhibit 99.1 hereto.

 

In addition, on October 3, 2023, the Company released an updated corporate overview presentation that it plans to use in meetings with investors. A copy of this presentation is furnished as Exhibit 99.2 hereto.

 

The information in this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

 

Description

99.1

 

Press Release of ASP Isotopes Inc. dated October 3, 2023

99.2

 

Corporate Overview Presentation of ASP Isotopes Inc. dated October 2023

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ASP ISOTOPES INC.

 

 

 

 

Date: October 3, 2023

By:

/s/ Paul Mann

 

 

Name:

Paul Mann

 

 

Title: 

Chief Executive Officer

 

 

 
3

 

nullnullv3.23.3
Cover
Oct. 03, 2023
Cover [Abstract]  
Entity Registrant Name ASP Isotopes Inc.
Entity Central Index Key 0001921865
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Oct. 03, 2023
Entity Ex Transition Period false
Entity File Number 001-41555
Entity Incorporation State Country Code DE
Entity Tax Identification Number 87-2618235
Entity Address Address Line 1 1101 Pennsylvania Avenue NW
Entity Address Address Line 2 Suite 300
Entity Address City Or Town Washington
Entity Address State Or Province DC
Entity Address Postal Zip Code 20004
City Area Code 202
Local Phone Number 756-2245
Security 12b Title Common Stock, par value $0.01
Trading Symbol ASPI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ASP Isotopes Charts.
ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ASP Isotopes Charts.